Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,255
Closed -$443K 1155
2025
Q4
$443K Buy
3,255
+36
+1% +$5.18K ﹤0.01% 823
2025
Q3
$475K Buy
3,219
+217
+7% +$30.1K ﹤0.01% 707
2025
Q2
$388K Buy
3,002
+86
+3% +$10.4K ﹤0.01% 786
2025
Q1
$348K Buy
2,916
+210
+8% +$26K ﹤0.01% 798
2024
Q4
$314K Hold
2,706
﹤0.01% 861
2024
Q3
$365K Sell
2,706
-31
-1% -$4.15K ﹤0.01% 772
2024
Q2
$371K Sell
2,737
-13
-0.5% -$1.77K ﹤0.01% 681
2024
Q1
$355K Buy
+2,750
New +$332K ﹤0.01% 800
2020
Q1
Sell
-4,465
Closed -$352K 947
2019
Q4
$352K Sell
4,465
-195
-4% -$15.2K ﹤0.01% 720
2019
Q3
$371K Buy
+4,660
New +$366K ﹤0.01% 547

Other funds holding XYL

ALPS Advisors's XYL Position: Q1 2026 in Review

ALPS Advisors sold out of Xylem (XYL) in Q1 2026, closing a stake of 3,255 shares — an estimated $443K sold.

ALPS Advisors first reported a position in XYL in Q3 2019 and held it in 10 quarters. The position peaked at $475K in Q3 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • ALPS Advisors reported no remaining Xylem position as of Q1 2026 after selling out during the quarter.
  • ALPS Advisors sold 3,255 Xylem shares in Q1 2026, an estimated $443K.
  • ALPS Advisors first reported a position in Xylem in Q3 2019 and held it in 10 quarters.
  • ALPS Advisors's Xylem position peaked at $475K in Q3 2025.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.